Project Grant R21NS139044
Award Date
9/4/24
Completion Date
8/31/26
Dollars Obligated
$390K
Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Lehigh University (E13MDBKHLDB5)
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Fountain Hill, PA 18015, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $224,070 to Nova Southeastern University to investigate the use of mesenchymal stromal cell-derived exosomes as probes to better understand immune cell dysfunction and mitochondrial function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The key research objectives are to: 1) Examine the effects of exosomes on immune cell...
The federal Project Grant award of $654,367.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant, awarded on January 1, 2025, supports research to investigate the neural mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 (PASC), also known as "Long COVID". The research aims to determine the relationship...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research provides $432,431 to San Jose State University Research Foundation to conduct research on red blood cell (RBC) deformability as a potential biomarker for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The 3-year project aims to use an ultra-high throughput microfluidic fractionator to sort RBC subpopulations and analyze their metabolic,...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $1,475,752.49 to New York University School of Medicine to conduct single-cell transcriptomic profiling of brain tissue from patients with Multiple System Atrophy (MSA). The goal is to generate an atlas of the MSA-dependent transcriptional changes across major cell types in the striatum,...
This Project Grant award of $517,546, awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to optimize, benchmark, and validate a novel multimodal microelectrode array (MEA) probe that integrates fast-scan cyclic voltammetry (FSCV) for sub-second neuromodulator sensing with parallel electrical recording. The research team, led by investigators from Dartmouth College, aims to develop this integrated MEA platform...
This $438,365 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to investigate the role of the CD38 protein and its potential as a therapeutic target for Spinal and Bulbar Muscular Atrophy (SBMA). The research aims to use stem cell technology and CRISPR-corrected isogenic controls to examine metabolic alterations in SBMA patient-derived...
This federal Project Grant award, totaling $653,192.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders, supports a longitudinal study on non-invasive imaging of pathological fibrin deposition and its effects on progressive neurodegeneration in the human brain. The study, conducted by the primary awardee The General Hospital Corporation (doing business as...
This $168,438 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA Program 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, will support a research project to characterize the phenotypic and neurophysiological features of cognitive dysfunction in individuals with fibromyalgia. The key objectives are to: 1) Compare subjective and objective cognitive assessments between individuals with fibromyalgia and healthy...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $979,138 to Decode Health, Inc. to conduct research on identifying RNA biomarkers that can distinguish between relapsing-remitting, primary progressive, and secondary progressive forms of multiple sclerosis (MS). The goal is to develop a multivariate machine learning-based blood test that can improve the diagnosis...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,702,003.00 to develop and assess the clinical potential of quantitative imaging biomarkers for evaluating changes in myofiber microstructure associated with masticatory myofascial pain syndrome (MMPS). The key products and services to be delivered include: 1) Establishing an optimal 15-minute MRI protocol and...